Amendment to Clinical Research Projects: Genetic Marking With Retroviral Vectors to Study the Feasibility of Stem Cell Gene Transfer and the Biology of Hematopoietic Reconstitution After Autologous Transplantation in Multiple Myeloma, Chronic Myelogenous Leukemia, or Metastatic Breast Cancer

This publication has 39 references indexed in Scilit:

• Safety Issues Related to Retroviral-Mediated Gene Transfer in Humans
  Human Gene Therapy, 1991
• The leukemia inhibitory factor (LIF)
  The International Journal of Cell Cloning, 1991
• Interleukin-6 is a cofactor for the growth of myeloid cells from human bone marrow aspirates but does not affect the clonogenicity of myeloma cells in vitro
  British Journal of Haematology, 1990
• Comparison of the Effects of Growth Factors on Retroviral Vector-Mediated Gene Transfer and the Proliferative Status of Human Hematopoietic Progenitor Cells
  Human Gene Therapy, 1990
• Gene Transfer into Humans — Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene Transduction
  New England Journal of Medicine, 1990
• Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.
  Journal of Clinical Investigation, 1990
• Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo‐radiotherapy?
  Hematological Oncology, 1989
• Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
  Nature, 1988
• Expression of human adenosine deaminase in nonhuman primates after retrovirus-mediated gene transfer.
  The Journal of Experimental Medicine, 1987
• DETECTION OF MICROMETASTASES IN PATIENTS WITH PRIMARY BREAST CANCER
  The Lancet, 1983